Research to be published online Nov. 24 in the journal Molecular Psychiatry may reveal the next step to developing an objective clinical laboratory blood tests for psychotic disease stations. Currently, there is no predictive blood test that identifies and prioritizes blood biomarkers for two key psychotic symptoms, one sensory (hallucinations) and one cognitive (delusions)...